RECELL GO Mini (≤480cm²)
Deep Partial / Full-Thickness Burns
Key Facts
About AVITA Medical
AVITA Medical is a mission-driven company focused on transforming lives through innovative therapeutic acute wound care solutions. Its core achievement is the FDA-approved RECELL® System, a disruptive autologous cell harvesting technology that has established a global commercial footprint in burn care. The company's strategy is to leverage the RECELL platform for label expansion into traumatic and surgical wounds while building a comprehensive acute wound care portfolio through complementary products like PermeaDerm® and Cohealyx™. This approach aims to drive growth by addressing significant unmet needs across the continuum of acute wound management.
View full company profileAbout AVITA Medical
AVITA Medical is a mission-driven company focused on transforming lives through innovative therapeutic acute wound care solutions. Its core achievement is the FDA-approved RECELL® System, a disruptive autologous cell harvesting technology that has established a global commercial footprint in burn care. The company's strategy is to leverage the RECELL platform for label expansion into traumatic and surgical wounds while building a comprehensive acute wound care portfolio through complementary products like PermeaDerm® and Cohealyx™. This approach aims to drive growth by addressing significant unmet needs across the continuum of acute wound management.
View full company profileAbout AVITA Medical
AVITA Medical is a mission-driven company focused on transforming lives through innovative therapeutic acute wound care solutions. Its core achievement is the FDA-approved RECELL® System, a disruptive autologous cell harvesting technology that has established a global commercial footprint in burn care. The company's strategy is to leverage the RECELL platform for label expansion into traumatic and surgical wounds while building a comprehensive acute wound care portfolio through complementary products like PermeaDerm® and Cohealyx™. This approach aims to drive growth by addressing significant unmet needs across the continuum of acute wound management.
View full company profileTherapeutic Areas
Other Deep Partial / Full-Thickness Burns Drugs
| Drug | Company | Phase |
|---|---|---|
| RECELL / RECELL GO (≤1920cm²) | AVITA Medical | Approved |